4//SEC Filing
Esperion Therapeutics, Inc. 4
Accession 0001179110-16-031173
$ESPRCIK 0001434868operating
Filed
Nov 2, 8:00 PM ET
Accepted
Nov 3, 5:58 PM ET
Size
5.1 KB
Accession
0001179110-16-031173
Insider Transaction Report
Form 4
Lalwani Narendra D.
Chief Operating Officer
Transactions
- Purchase
Common Stock
2016-11-01$9.93/sh+5,000$49,650→ 5,000 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.85 to $10.03, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4
Documents
Issuer
Esperion Therapeutics, Inc.
CIK 0001434868
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001434868
Filing Metadata
- Form type
- 4
- Filed
- Nov 2, 8:00 PM ET
- Accepted
- Nov 3, 5:58 PM ET
- Size
- 5.1 KB